Genotype Distribution Characteristics of High-risk Human Papillomaviruses in Women from Shanghai, China

Overview

Journal Epidemiol Infect

Publisher Cambridge University Press

Specialties Infectious Diseases
Public Health

Date 2015 Nov 12

PMID 26554879

Citations 8

Authors

Y Gu

M Yi

Y Xu

H Zhao

F Fu

Y Zhang

Affiliations

Soon will be listed here.

Abstract

High-risk human papillomaviruses (HPVs) are highly prevalent worldwide, and HPV genotype distribution varies regionally. Molecular surveys of HPVs are important for effective HPV control and prevention. Fifteen high-risk HPV strains (16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) and six low-risk HPV strains (HPV6, 11, 42, 43, 44, CP8304) were detected by cervical cytology from 10 501 subjects. High-risk HPVs, low-risk HPVs, and both high- and low-risk HPVs were detected in 14·5%, 2·8%, and 2·4% of cases, respectively. Of 1782 subjects with high-risk HPV infection, 75·5%, 18·1%, and 6·4% were infected with one, two, and ⩾3 strains of high-risk HPVs, respectively. HPV52, HPV16, and HPV58 were the top three most dominant high-risk HPV genotypes in our population with positivity rates of 23·0%, 17·7% and 16·9%, respectively. Multiple infection was common, with significantly higher co-infection rates of HPV58/HPV33 (12·9%) and HPV58/HPV52 (11·3%). Further data comparisons showed that HPV genotype distribution varied markedly between domestic and international regions. In conclusion, a monolithic vaccination strategy is obviously impractical, and regional HPV surveillance is essential to optimize current HPV control and prevention.

Citing Articles

HPV prevalence and genotype distribution among 38 056 women in Weifang, China: a cross-sectional study.

Liu M, Zhang X, Guo L, Sun W, Jiang X BMJ Open. 2023; 13(9):e073332.

PMID: 37669845 PMC: 10481741. DOI: 10.1136/bmjopen-2023-073332.

Absolute Risk and Attributable Fraction of Type-Specific Human Papillomavirus in Cervical Cancer and Precancerous Lesions-A Population-Based Study of 6286 Women in Rural Areas of China.

Li L, Jiang M, Li T, Yin J, Feng R, Dong L J Clin Med. 2022; 11(21).

PMID: 36362711 PMC: 9655002. DOI: 10.3390/jcm11216483.

Molecular characterization of high-risk humanpapillomavirus genotypes in women with or without cervical lesions at VIA/VILI in Kara, Togo.

Dolou E, Kuassi-Kpede A, Zohoncon T, Traore I, Katawa G, Ouedraogo A Afr Health Sci. 2022; 21(4):1715-1721.

PMID: 35283946 PMC: 8889811. DOI: 10.4314/ahs.v21i4.27.

The Prevalence of Thrice, Twice, and Once Human Papillomavirus DNA Positivity in Older Chinese Women.

Hu G, Xu J, Xu L, Jin L Front Med (Lausanne). 2020; 7:391.

PMID: 32984359 PMC: 7492668. DOI: 10.3389/fmed.2020.00391.

Distribution characteristics of different human papillomavirus genotypes in women in Wuhan, China.

Xiang F, Guan Q, Liu X, Xiao H, Xia Q, Liu X J Clin Lab Anal. 2018; 32(8):e22581.

PMID: 29862560 PMC: 6220820. DOI: 10.1002/jcla.22581.

References

Macedo Barcelos A, Michelin M, Adad S, Murta E . Atypical squamous cells of undetermined significance: Bethesda classification and association with Human Papillomavirus. Infect Dis Obstet Gynecol. 2011; 2011:904674. PMC: 3132509. DOI: 10.1155/2011/904674. View

Johansson C, Schwartz S . Regulation of human papillomavirus gene expression by splicing and polyadenylation. Nat Rev Microbiol. 2013; 11(4):239-51. DOI: 10.1038/nrmicro2984. View

Hong H, He T, Ni H, Zhang S, Xu G . Prevalence and genotype distribution of HPV infection among women in Ningbo, China. Int J Gynaecol Obstet. 2015; 131(1):96-9. DOI: 10.1016/j.ijgo.2015.04.027. View

Munoz N, Bosch F, de Sanjose S, Herrero R, Castellsague X, Shah K . Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348(6):518-27. DOI: 10.1056/NEJMoa021641. View

Bian T, Wang Y, Lu Z, Ye Z, Zhao L, Ren J . Human papillomavirus type 16 L1E7 chimeric capsomeres have prophylactic and therapeutic efficacy against papillomavirus in mice. Mol Cancer Ther. 2008; 7(5):1329-35. DOI: 10.1158/1535-7163.MCT-07-2015. View

Ghittoni R, Accardi R, Chiocca S, Tommasino M . Role of human papillomaviruses in carcinogenesis. Ecancermedicalscience. 2015; 9:526. PMC: 4431404. DOI: 10.3332/ecancer.2015.526. View

Bhatla N, Lal N, Bao Y, Ng T, Qiao Y . A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination. Vaccine. 2008; 26(23):2811-7. DOI: 10.1016/j.vaccine.2008.03.047. View

Abbate E, Voitenleitner C, Botchan M . Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association. Mol Cell. 2006; 24(6):877-89. DOI: 10.1016/j.molcel.2006.11.002. View

Chew G, Cruickshank M, Rooney P, Miller I, Parkin D, Murray G . Human papillomavirus 16 infection in adenocarcinoma of the cervix. Br J Cancer. 2005; 93(11):1301-4. PMC: 2361519. DOI: 10.1038/sj.bjc.6602855. View

10.

Lacey C, Lowndes C, Shah K . Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine. 2006; 24 Suppl 3:S3/35-41. DOI: 10.1016/j.vaccine.2006.06.015. View

11.

Saraiya M, Unger E, Thompson T, Lynch C, Hernandez B, Lyu C . US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015; 107(6):djv086. PMC: 4838063. DOI: 10.1093/jnci/djv086. View

12.

Kreimer A, Clifford G, Boyle P, Franceschi S . Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005; 14(2):467-75. DOI: 10.1158/1055-9965.EPI-04-0551. View

13.

Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J . Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States. MMWR Morb Mortal Wkly Rep. 2014; 63(29):620-4. PMC: 5779422. View

14.

Wheeler C, Hunt W, Joste N, Key C, Quint W, Castle P . Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst. 2009; 101(7):475-87. PMC: 2664090. DOI: 10.1093/jnci/djn510. View

15.

Elrefaey S, Massaro M, Chiocca S, Chiesa F, Ansarin M . HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol Ital. 2015; 34(5):299-309. PMC: 4299160. View

16.

Munoz N, Castellsague X, Berrington de Gonzalez A, Gissmann L . Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006; 24 Suppl 3:S3/1-10. DOI: 10.1016/j.vaccine.2006.05.115. View

17.

de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N . Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007; 7(7):453-9. DOI: 10.1016/S1473-3099(07)70158-5. View

18.

Winer R, Hughes J, Feng Q, OReilly S, Kiviat N, Holmes K . Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med. 2006; 354(25):2645-54. DOI: 10.1056/NEJMoa053284. View

19.

Xue H, Lin X, Li T, Yan X, Guo K, Zhang Y . Prevalence and genotype distribution of human papillomavirus infection in asymptomatic women in Liaoning province, China. J Med Virol. 2015; 87(7):1248-53. DOI: 10.1002/jmv.24029. View

20.

Zhi Y, Cha X, Li X, Qiu C, Rong S . Prevalence and genotype distribution of human papillomavirus in women in the Henan Province. Genet Mol Res. 2015; 14(2):5452-61. DOI: 10.4238/2015.May.22.15. View